FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

By Elaine Kolodziej Over-the-counter meds Lawmakers in Texas are considering joining Arkansas, Tennessee, and Idaho in allowing over-the-counter access to Ivermectin. State Rep. Joanne Shofner has ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

President Trump’s first 100 days has roiled health and science as part of the administration’s plan to reshape the federal ...

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...